A Lanza

539 total citations
20 papers, 386 citations indexed

About

A Lanza is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, A Lanza has authored 20 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in A Lanza's work include Hematopoietic Stem Cell Transplantation (7 papers), Cancer Cells and Metastasis (4 papers) and Mesenchymal stem cell research (3 papers). A Lanza is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Cancer Cells and Metastasis (4 papers) and Mesenchymal stem cell research (3 papers). A Lanza collaborates with scholars based in Italy and United States. A Lanza's co-authors include G. Robustelli della Cuna, Francesco Bertolini, Paolo Pedrazzoli, Manuela Battaglia, Antonia M. Pedrini, Silvia Tornaletti, Carlo Rodolfo, Gian Antonio Da Prada, Lorenza Caneva and Barbara Sarina and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

A Lanza

20 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Lanza Italy 8 164 159 103 56 50 20 386
Shiho Fujiwara Japan 8 125 0.8× 195 1.2× 130 1.3× 42 0.8× 51 1.0× 16 323
Giuseppe Monaco Italy 9 83 0.5× 206 1.3× 48 0.5× 69 1.2× 27 0.5× 22 398
K Sampi Japan 11 162 1.0× 199 1.3× 137 1.3× 54 1.0× 22 0.4× 55 476
N. H. Russell United Kingdom 12 201 1.2× 255 1.6× 129 1.3× 88 1.6× 40 0.8× 17 454
V Ruppert Germany 10 205 1.3× 308 1.9× 205 2.0× 130 2.3× 66 1.3× 13 552
Irina Mantovani Italy 8 74 0.5× 291 1.8× 98 1.0× 42 0.8× 38 0.8× 10 381
Stephen M. Hart United Kingdom 9 57 0.3× 243 1.5× 121 1.2× 33 0.6× 27 0.5× 10 367
Maria Dan United States 10 50 0.3× 121 0.8× 94 0.9× 61 1.1× 19 0.4× 22 319
Kwang-Sung Ahn South Korea 11 100 0.6× 195 1.2× 76 0.7× 29 0.5× 32 0.6× 18 317
Youwen Qin China 11 118 0.7× 197 1.2× 61 0.6× 35 0.6× 64 1.3× 25 344

Countries citing papers authored by A Lanza

Since Specialization
Citations

This map shows the geographic impact of A Lanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Lanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Lanza more than expected).

Fields of papers citing papers by A Lanza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Lanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Lanza. The network helps show where A Lanza may publish in the future.

Co-authorship network of co-authors of A Lanza

This figure shows the co-authorship network connecting the top 25 collaborators of A Lanza. A scholar is included among the top collaborators of A Lanza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Lanza. A Lanza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lanza, A, et al.. (2016). A case of advanced second-degree atrioventricular block in a ferret secondary to lymphoma. Open Veterinary Journal. 6(1). 68–68. 2 indexed citations
2.
Lanza, A, Aldo Tava, Maddalena Catalano, et al.. (2004). Effects of the Medicago scutellata trypsin inhibitor (MsTI) on cisplatin-induced cytotoxicity in human breast and cervical cancer cells.. PubMed. 24(1). 227–33. 27 indexed citations
4.
Gibelli, Nadia, A Lanza, Paolo Pedrazzoli, et al.. (2000). Minimal tumor contamination of hematopoietic harvests from breast cancer patients can be easily detected by liquid culture assay. Cytotherapy. 2(1). 39–44. 1 indexed citations
5.
Lanza, A, Francesco Saverio Robustelli della Cuna, Carlo Zibera, Paolo Pedrazzoli, & G. Robustelli della Cuna. (1999). Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations: comparison with sister chromatid exchange frequency. International Archives of Occupational and Environmental Health. 72(5). 315–322. 19 indexed citations
6.
Zibera, Carlo, Paolo Pedrazzoli, Luisa Ponchio, et al.. (1999). Efficacy of epirubicin/paclitaxel combination in mobilizing large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen.. PubMed. 84(10). 924–9. 5 indexed citations
7.
Battaglia, Manuela, Paolo Pedrazzoli, Belinda Palermo, et al.. (1998). Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: a new sensitive one step method without false positive results. Bone Marrow Transplantation. 22(7). 693–698. 30 indexed citations
9.
Bertolini, Francesco, Manuela Battaglia, A Lanza, et al.. (1998). Stem cell enumeration in cord blood vs bone marrow and peripheral blood.. PubMed. 22 Suppl 1. S57–S57. 3 indexed citations
10.
Bertolini, Francesco, Manuela Battaglia, A Lanza, et al.. (1998). Hematopoietic stem cells from different sources: biological and technical aspects.. PubMed. 21 Suppl 2. S5–7. 5 indexed citations
11.
Bertolini, Francesco, Manuela Battaglia, A Lanza, Belinda Palermo, & G. Robustelli della Cuna. (1998). Control of stem cell proliferation and differentiation to achieve stable gene transfer and expression.. PubMed. 21 Suppl 3. S75–6. 1 indexed citations
12.
Pedrazzoli, Paolo, Manuela Battaglia, A Lanza, et al.. (1997). Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy. Bone Marrow Transplantation. 20(2). 167–169. 18 indexed citations
13.
Lanza, A, et al.. (1997). Chromosomal fragility in the cancer-prone disease xeroderma pigmentosum preferentially involves bands relevant for cutaneous carcinogenesis. International Journal of Cancer. 74(6). 654–660. 7 indexed citations
14.
Bertolini, Francesco, Manuela Battaglia, Paolo Pedrazzoli, et al.. (1997). Megakaryocytic Progenitors Can Be Generated Ex Vivo and Safely Administered to Autologous Peripheral Blood Progenitor Cell Transplant Recipients. Blood. 89(8). 2679–2688. 140 indexed citations
15.
Bertolini, Francesco, Manuela Battaglia, A Lanza, et al.. (1997). Multilineage Long-Term Engraftment Potential of Drug-Resistant Hematopoietic Progenitors. Blood. 90(8). 3027–3036. 26 indexed citations
16.
Lanza, A, et al.. (1996). Human DNA Topoisomerase I-mediated Cleavages Stimulated by Ultraviolet Light-induced DNA Damage. Journal of Biological Chemistry. 271(12). 6978–6986. 65 indexed citations
17.
Rodolfo, Carlo, A Lanza, Silvia Tornaletti, Gilberto Fronza, & Antonia M. Pedrini. (1994). The ultimate carcinogen of 4-nitroquinoline 1-oxide does not react with Z-DNA and hyperreacts with B-Z junctions. Nucleic Acids Research. 22(3). 314–320. 17 indexed citations
18.
Lanza, A, Silvia Tornaletti, Miria Stefanini, et al.. (1993). The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases. Carcinogenesis. 14(9). 1759–1763. 6 indexed citations
19.
Lanza, A, et al.. (1992). Trisomy 21 mosaicism in two subjects from two generations.. PubMed. 35(4). 245–50. 3 indexed citations
20.
Guercio, E, et al.. (1988). The place of pelvic exenteration in surgical management of advanced and recurrent pelvic tumors.. PubMed. 9(5). 420–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026